News & Insights

Gide advises the banks’ syndicate, including Leerink Partners, Morgan Stanley, Piper Sandler & Co. and Guggenheim Securities, as joint bookrunning...

Gide advised Veolia Environnement on its €400 million non-dilutive cash-settled convertible bonds issuance, maturing in 2032.The bonds bear interest a...

Gide advises the banks’ syndicate, including TD Cowen and Stifel, as joint global coordinators and joint placement agents, on the €50 million equity o...

Gide advised Inventiva, a biopharmaceutical company listed on Euronext Paris and the NASDAQ Global Market, specializing in the development of oral the...

Gide advises the banks’ syndicate, including Jefferies, TD Cowen and Stifel, as global coordinators and joint bookrunners, on $100 million (correspond...

Gide has advised the banking syndicate composed of Leerink Partners, Stifel and Baird on the €60 million financing by Sensorion, including a €20 milli...

Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associ...

Gide advises the banks’ syndicate, including Leerink Partners, Piper Sandler & Co. and Guggenheim Securities, as joint bookrunning managers, LifeS...

Gide advised Agence des Participations de l’Etat on Eutelsat’s capital strengthening project. Eutelsat plans to raise €1.35 billion in capital through...

Gide has advised Inventiva, a biopharmaceutical company listed on Euronext Paris and Nasdaq, on the issuance of the second tranche of the structured f...